| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 9 | |
| #2 | WIPO (World Intellectual Property Organization) | 9 | |
| #3 | China | 8 | |
| #4 | EPO (European Patent Office) | 7 | |
| #5 | United States | 6 | |
| #6 | Israel | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Climate change adaptation technologies | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tavernier Jan | 40 |
| #2 | Kley Nikolai | 40 |
| #3 | Cauwels Anje | 17 |
| #4 | Peelman Frank | 9 |
| #5 | Gerlo Sarah | 9 |
| #6 | Huyghe Leander | 8 |
| #7 | Zabeau Lennart | 5 |
| #8 | Wueest Thomas | 4 |
| #9 | Van Lint Sandra | 4 |
| #10 | Jan Tavernier | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018141964A1 | Targeted chimeric proteins and uses thereof | |
| CN110114368A | Target mutation disturbance element-γ and application thereof | |
| CN109689087A | Targeting mutation disturbance element-β and application thereof | |
| WO2017194782A2 | Therapeutic targeting of non-cellular structures | |
| US2019352406A1 | Clec9a binding agents | |
| CA3003969A1 | Bi-functional chimeric proteins and uses thereof |